The transfer of the serum after treatment into recipient mice effectively causes arthritis, indicating a shared mechanism enhancing the pathogenic functions of autoantibodies via the transformation of sialylated IgG into a glycosylated state via the IL-23/Th17 axis in both arthritis models [160]. The gene discussed is IL23A; the disease is arthritic joint disease.